IP Library Patent Application 16953110
Patent Application
App. No. 16/953,110

NUTRITIONAL SUPPLEMENT FOR IMPROVING SEXUAL HEALTH IN MEN AND WOMEN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/953,110
Abstract

The invention provides compositions and methods that are effective to improve NO production in vivo and/or to increase NO levels in blood. Such compositions and methods are useful to improve sexual function in males and females.

Claims (27)

1 . A unit dosage form suitable for oral administration to a human comprising:

L-citrulline 500 mg±20 mg;

L-arginine 250 mg±20 mg; and

at least about 5 mg piperine.

2 . The unit dosage form of claim 1 that comprises at least about 5.0 mg piperine.

3 . The unit dosage form of claim 1 that comprises at least about 5.3 mg piperine.

4 . The unit dosage form of claim 1 that comprises at least about 5.5 mg piperine.

5 . The unit dosage form of claim 1 that further comprises microcrystalline cellulose, silicon dioxide, and magnesium stearate.

6 . The unit dosage form of claim 1 that comprises at least about 480 mg of L-citrulline.

7 . The unit dosage form of claim 1 that comprises at least about 490 mg of L-citrulline.

8 . The unit dosage form of claim 1 that comprises at least about 500 mg of L-citrulline.

9 . The unit dosage form of claim 1 that comprises at least about 230 mg of L-arginine.

10 . The unit dosage form of claim 1 that comprises at least about 240 mg of L-arginine.

11 . The unit dosage form of claim 1 that comprises at least about 250 mg of L-arginine.

12 . The unit dosage form of claim 1 that comprises:

about 500 mg of L-citrulline;

about 250 mg of L-arginine; and

about 1.75 mg of bioperine.

13 . The unit dosage form of claim 1 wherein the piperine is synthetically produced piperine.

14 . The unit dosage form of claim 1 the piperine is an extract from the fruit of Piper.

15 . The unit dosage form of claim 12 that further comprises microcrystalline cellulose, silicon dioxide, and magnesium stearate.

16 . The unit dosage form of claim 1 that is formulated as a capsule, powder or liquid.

17 . A method to increase NO levels in the blood of a mammal comprising administering a unit dosage form of claim 1 to the mammal.

18 . A method to treat erectile dysfunction in a mammal comprising administering a unit dosage form of claim 1 to the mammal.

19 . A method to improve sexual function in a mammal comprising administering a unit dosage form of claim 1 to the mammal.

20 . A method to improve erection hardness, erection maintenance, frequency of intercourse, partner satisfaction, or overall satisfaction with sexual health in a male human comprising administering a unit dosage form of claim 1 to the male human.

21 . A method to improve lubrication, sexual desire, ability to be aroused or frequency of intercourse, in a female human comprising administering a unit dosage form of claim 1 to the female human.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 14, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 067728/0206 →
SECURITY INTEREST Recorded Feb 10, 2022
From: INNOVUS PHARMACEUTICALS, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 058976/0706 →
SECURITY INTEREST Recorded Jan 27, 2022
From: INNOVUS PHARMACEUTICALS, INC.; SEMPRAE LABORATORIES, INC.
To: ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), AS AGENT
Reel/Frame 058789/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2020
From: DAMAJ, BASSAM
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 054470/0409 →